TEL AVIV, May 9 (Reuters) – Teva Pharmaceutical Industries’
, the world’s biggest generic drugmaker, reported
better-than-expected first-quarter profits on Monday and said it
still expected its $40.5…
The post UPDATE 1-Teva Pharm’s quarterly profit beats forecast, sees Actavis deal closing in June appeared first on NASDAQ.